Correlation Between Nkarta and Coeptis Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nkarta and Coeptis Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nkarta and Coeptis Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nkarta Inc and Coeptis Therapeutics Holdings, you can compare the effects of market volatilities on Nkarta and Coeptis Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nkarta with a short position of Coeptis Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nkarta and Coeptis Therapeutics.

Diversification Opportunities for Nkarta and Coeptis Therapeutics

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Nkarta and Coeptis is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Nkarta Inc and Coeptis Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coeptis Therapeutics and Nkarta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nkarta Inc are associated (or correlated) with Coeptis Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coeptis Therapeutics has no effect on the direction of Nkarta i.e., Nkarta and Coeptis Therapeutics go up and down completely randomly.

Pair Corralation between Nkarta and Coeptis Therapeutics

Given the investment horizon of 90 days Nkarta is expected to generate 22.28 times less return on investment than Coeptis Therapeutics. But when comparing it to its historical volatility, Nkarta Inc is 6.66 times less risky than Coeptis Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Coeptis Therapeutics Holdings is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  8.22  in Coeptis Therapeutics Holdings on August 31, 2024 and sell it today you would lose (6.22) from holding Coeptis Therapeutics Holdings or give up 75.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy78.07%
ValuesDaily Returns

Nkarta Inc  vs.  Coeptis Therapeutics Holdings

 Performance 
       Timeline  
Nkarta Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nkarta Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Coeptis Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Coeptis Therapeutics Holdings are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Coeptis Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Nkarta and Coeptis Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nkarta and Coeptis Therapeutics

The main advantage of trading using opposite Nkarta and Coeptis Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nkarta position performs unexpectedly, Coeptis Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coeptis Therapeutics will offset losses from the drop in Coeptis Therapeutics' long position.
The idea behind Nkarta Inc and Coeptis Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.